Specifically, HRDsig can identify BRCA1 promoter hypermethylation in ovarian cancer, a key epigenetic alteration that leads to silencing of the BRCA1 gene and contributes to HRD [22,31]. This evidence concerns the gene BRCA1 and ovarian carcinoma.